Related references
Note: Only part of the references are listed.Oncogenic and tumor suppressive roles of microRNAs in apoptosis and autophagy
Y. Chen et al.
APOPTOSIS (2014)
MicroRNAs in Colorectal Cancer: from Diagnosis to Targeted Therapy
Ayla Valinezhad Orang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches
Qiong Wu et al.
CANCER LETTERS (2014)
Targeting the microRNA-regulating DNA damage/repair pathways in cancer
Giulia Bottai et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2014)
PHLPP Is a Negative Regulator of RAF1, Which Reduces Colorectal Cancer Cell Motility and Prevents Tumor Progression in Mice
Xin Li et al.
GASTROENTEROLOGY (2014)
miR200c Attenuates P-gp-Mediated MDR and Metastasis by Targeting JNK2/c-Jun Signaling Pathway in Colorectal Cancer
Hua Sui et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Acquired resistance to EGFR-targeted therapies in colorectal cancer
Beth O. Van Emburgh et al.
MOLECULAR ONCOLOGY (2014)
MicroRNA-147 Induces a Mesenchymal-To-Epithelial Transition (MET) and Reverses EGFR Inhibitor Resistance
Chang Gong Lee et al.
PLOS ONE (2014)
MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression
Lekun Fang et al.
ONCOTARGET (2014)
MicroRNAs 146a and 147b Biomarkers for Colorectal Tumor's Localization
Ines Omrane et al.
BIOMED RESEARCH INTERNATIONAL (2014)
miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer
Y. Shen et al.
BRITISH JOURNAL OF CANCER (2013)
MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer
Neha Nagpal et al.
CARCINOGENESIS (2013)
microRNA-224 Promotes Cell Proliferation and Tumor Growth in Human Colorectal Cancer by Repressing PHLPP1 and PHLPP2
Wen-Ting Liao et al.
CLINICAL CANCER RESEARCH (2013)
microRNA 223 Is Upregulated in the Multistep Progression of Barrett's Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1
Mirte Mayke Streppel et al.
CLINICAL CANCER RESEARCH (2013)
Clinical significance of microRNA-93 downregulation in human colon cancer
Zhi-Gang Xiao et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2013)
miR-1915 inhibits Bcl-2 to modulate multidrug resistance by increasing drug-sensitivity in human colorectal carcinoma cells
Ke Xu et al.
MOLECULAR CARCINOGENESIS (2013)
MicroRNA-21 as a potential colon and rectal cancer biomarker
Tao Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status
Gianpiero Di Leva et al.
PLOS GENETICS (2013)
MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells
Weiwei Cheng et al.
FEBS JOURNAL (2012)
Identification and functional screening of microRNAs highly deregulated in colorectal cancer
Petra Faltejskova et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
PARP1 inhibitors attenuate AKT phosphorylation via the upregulation of PHLPP1
Shuai Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Apoptomirs: small molecules have gained the license to kill
Andrea Vecchione et al.
ENDOCRINE-RELATED CANCER (2010)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Loss of PHLPP expression in colon cancer: role in proliferation and tumorigenesis
J. Liu et al.
ONCOGENE (2009)
Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cells
Roberto Bianco et al.
CLINICAL CANCER RESEARCH (2008)
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues
E. Bandres et al.
MOLECULAR CANCER (2006)
PHLPP: A phosphatase that directly dephosphorylates akt, promotes apoptosis, and suppresses tumor growth
TY Gao et al.
MOLECULAR CELL (2005)
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy
F Ciardiello et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
